Pharmacokinetics of enrofloxacin after intravenous and intramuscular administration in Angora goats

Canadian Journal of Veterinary Research

Volumn 65, Issue 1, 2001, Pages 62-67

  Elmas, M ^a   Tras, B ^a   Kaya, S ^a   Bas, A L ^a   Yazar, E ^a   Yarsan, E ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ENROFLOXACIN; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANIMAL DISEASE; ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG HALF LIFE; GOAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ANIMAL; BLOOD; COMMUNICABLE DISEASE; CROSSOVER PROCEDURE; GOAT DISEASE; HALF LIFE TIME; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MICROBIOLOGICAL EXAMINATION;

ANIMALS; ANTI-INFECTIVE AGENTS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMMUNICABLE DISEASES; CROSS-OVER STUDIES; FLUOROQUINOLONES; GOAT DISEASES; GOATS; HALF-LIFE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; MICROBIAL SENSITIVITY TESTS; QUINOLONES;

EID: 0035220821     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Results of clinical studies with Baytril in dogs and cats
2. Studies on antimicrobial activity of Baytril
3. The flouroquinolone antimicrobials: Structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity
4. Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs
5. Pharmacokinetics of (1-cyclopropyl-6-flouro-1,4-dihydro-4-oxo-7[4-ethyl-1piperazinyl]-3- quinolinecarboxylic acid (CFPQ) in preruminant and ruminant calves
6. Pharmacokinetics of enrofloxacin in newborn and one-week-old calves
7. Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows
8. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs
9. Pharmacokinetics properties of enrofloxacin in rabbits
10. Limited capacity of neonatal rabbits to eliminate enrofloxacin and ciprofloxacin
11. Pharmacokinetics of enrofloxacin in horses after single intravenous and intramuscular administration
12. Comparison of pharmacokinetic profiles of some antimicrobial agents in plasma and lymph fluids
13. Pharmacokinetics of enrofloxacin and its metabolite, ciprofloxacin, after intravenous and intramuscular administrations in sheep
14. Pharmacokinetics and residues of enrofloxacin in chickens
15. Concentrations of active ingredient in serum and tissues after oral and parenteral administration of Baytril
16. PKCALC: A Basic interactive computer program for statistical and pharmacokinetic analysis of data
17. Pharmacokinetics of enrofloxacin after intravenous and intramuscular injection in rabbits
18. Sustained release of liposome-encapsulated enrofloxacin after intramuscular administration in rabbits
19. Pharmacodynamics of antimicrobial agents as a basis for determination dosage regimens